· Vice President Clinical Development, Nurix Therapeutics2025–
· SVP, CMO, HanchorBio Inc. 漢康生技股份有限公司2024–2025
· Vice President Clinical Development, Rigel Pharmaceuticals Inc.2022–2024
· Executive Medical Director, Rigel Pharmaceuticals Inc.2019–2022
· Senior Medical Director, Adverum Biotechnologies, Inc.2018–2019
· Medical Director, Amgen2006–2018
· Sr. Associate Medical Director, Amgen2003–2006
· Clinical Scientist, Pfizer2001–2003
· Post-Doctoral Fellow, Oncology and Cancer Biology, The Johns Hopkins University School of Medicine1999–2001
· Ph.D, Pharmacogenomics, Clinical Pharmacology, Mayo Clinic Graduate School of Biomedical Sciences1994–1999
· School of Medicine, MD, MS, Medicine, Pharmacology, Zhejiang University1983–1993